secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001493152-24-050120
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab projects $10M revenue with 250-300 physicians at >65% gross margins
--------------------------------------------------------------------------

- Single provider using full suite can generate $30-50k annual revenue for QHSLab.
- Allergy kits ~$100/test; immunotherapy ~$500/patient/year; digital tools $20-40/patient.
- Targeting 250-300 physicians to drive over $10M annual revenue at >65% gross margins.
- Paid $215k to Mercer debt from cashflow; plans to eliminate debt with new capital.
- Expanding sales force by 5 reps in TX, GA, NY; QHS Behavioral Centers by Q2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/0001493152-24-050120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer